Novomate 277.8 mg/ml powder and solvent for suspension for injection for cattle
Novomate 277.8 mg/ml powder and solvent for suspension for injection for cattle
Authorised
- Penethamate hydriodide
Product identification
Medicine name:
Novomate 277.8 mg/ml powder and solvent for suspension for injection for cattle
Active substance:
- Penethamate hydriodide
Target species:
-
Cattle
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Penethamate hydriodide277.80/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Powder and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal10day
-
Milk96hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Powder:Colourless, glass vials (siliconised) (50 ml) (type II) closed with rubber stoppers (bromobutyl) and aluminium caps.Solvent:Colourless, glass vials (50 ml) (type II) closed with rubber stoppers (bromobutyl) and aluminium caps.Pack sizes:Cardboard box with 1 pair of vials (10 g powder and 30 ml solvent)
- Powder:Colourless, glass vials (siliconised) (30 ml) (type I) closed with rubber stoppers (bromobutyl) and aluminium caps.Solvent:Colourless, glass vials (20 ml) (type I) closed with rubber stoppers (bromobutyl) and aluminium caps.Pack sizes:Cardboard box with 6 pairs of vials (5 g powder and 15 ml solvent)
- Powder:Colourless, glass vials (siliconised) (30 ml) (type I) closed with rubber stoppers (bromobutyl) and aluminium caps.Solvent:Colourless, glass vials (20 ml) (type I) closed with rubber stoppers (bromobutyl) and aluminium caps.Pack sizes:Cardboard box with 2 pairs of vials (5 g powder and 15 ml solvent)
- Powder:Colourless, glass vials (siliconised) (30 ml) (type I) closed with rubber stoppers (bromobutyl) and aluminium caps.Solvent:Colourless, glass vials (20 ml) (type I) closed with rubber stoppers (bromobutyl) and aluminium caps.Pack sizes:Cardboard box with 1 pair of vials (5 g powder and 15 ml solvent)
- Powder:Colourless, glass vials (siliconised) (50 ml) (type II) closed with rubber stoppers (bromobutyl) and aluminium caps.Solvent:Colourless, glass vials (50 ml) (type II) closed with rubber stoppers (bromobutyl) and aluminium caps.Pack sizes:Cardboard box with 6 pairs of vials (10 g powder and 30 ml solvent)
- Powder:Colourless, glass vials (siliconised) (50 ml) (type II) closed with rubber stoppers (bromobutyl) and aluminium caps.Solvent:Colourless, glass vials (50 ml) (type II) closed with rubber stoppers (bromobutyl) and aluminium caps.Pack sizes:Cardboard box with 2 pairs of vials (10 g powder and 30 ml solvent)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Lohmann Pharma Herstellung GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Lohmann Pharma Herstellung GmbH
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0613/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
France
-
Netherlands
-
Poland
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 24/08/2025
Updated on: 13/03/2026
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.